emerging healthcare firms

The IPO performance of emerging healthcare firms in the United States has become an increasingly scrutinized indicator of both innovation cycles and capital market sentiment. Over the past decade, biotech and healthcare IPOs have served as a key financing pathway for clinical-stage companies seeking to transition from R&D to commercialization. However, post-listing performance has revealed … Read more